Overview
Vladonix is a natural peptide bioregulator extracted from young animal thymus gland tissue, containing thymus-specific signaling peptides.
What problem it targets: It targets severe immune exhaustion, chronic infections, post-chemotherapy immune recovery, autoimmune flare-ups, and systemic biological aging.
What It Does
• Restores cellular and humoral immunity: Supplies bio-identical thymic peptides that signal bone marrow and lymphoid tissue to produce and train mature, functional T-cells.
• Balances immune cell ratios: Normalizes the delicate ratio of helper T-cells to cytotoxic/suppressor T-cells, reducing auto-reactivity while maximizing defense against pathogens.
• Reverses thymus involution: Helps counter the natural age-related shrinking of the thymus gland, maintaining robust immunocompetence into older age.
• Realistic expectations: Taken in 10- to 30-day courses once or twice per year. A foundational longevity and immune-support peptide that steadily rebuilds total immune defense.
Reconstitution
Finished oral extract: no reconstitution. This profile describes the referenced capsule or sublingual product. A 20 mg dry vial sold under the same name needs its own ingredient identity and supplier preparation instructions.
Presentation
The referenced preparation is a finished tissue-extract supplement. Capsule content and total capsule weight are different; use the exact product label.
Protocol
Community protocols & cycle timing
| Phase | Frequency | Amount | Notes |
|---|---|---|---|
| Common community cycle pattern | 10–20 consecutive days; a few courses per year with months between courses | Compound- and formulation-specific; see rows below | A shared cycle duration does not establish one shared dose. Oral labels may specify 30-day initial courses or 10-day maintenance courses. |
Product directions
| Phase | Frequency | Amount | Notes |
|---|---|---|---|
| Referenced capsule product directions | 1–2 times daily with meals; one month | 1–2 capsules per intake | Describes the cited retail formulation, not a clinically established regimen. Verify the current product label; other versions differ. |
| Vladonix Lingual listing | 3–4 times daily, 10–15 minutes before eating; one month | 5–6 drops (0.25–0.35 mL) per intake | Sublingual retail directions. The listing states 10 mg complex per 1 mL. Not equivalent to capsule dosing. |
About these protocols
The community rows describe reported experience, not a standard or recommended human regimen. Product-label rows apply to the cited formulation; cell and animal rows describe research models. Oral extracts are kept separate from synthetic peptide vials.
Handling & Stacking
- Bioregulators are often discussed as short 10–20-day courses, repeated a few times a year with months between courses, rather than continuous daily use.
- This describes a community cycle pattern, not one universal dose.
- Some finished oral products instead specify a 30-day course or 10-day maintenance course.
- The referenced capsule products are stored dry and protected from light, at +2°C to +25°C.
- Use the expiry date on the actual pack.
- Liquid products may have different storage and opened-container instructions.
- The named preparation is not established here as an approved treatment for its marketed goals.
- Approved alternatives depend on the diagnosed condition and cannot be assigned from an organ label alone.
Safety & Patient Education
- Referenced capsule labels list intolerance to ingredients, pregnancy and lactation as contraindications.
- These are label statements; they do not prove safety in every other situation.
